Cancer associated thrombosis and mortality in patients with cancer stratified by khorana score risk levels
Sign Up to like & getrecommendations! Published in 2020 at "Cancer Medicine"
DOI: 10.1002/cam4.3437
Abstract: The Khorana score (KS) clinical algorithm is used to predict VTE risk in cancer patients. The study objective was to evaluate VTE and survival rates among patients newly diagnosed with cancer and stratified by KS… read more here.
Keywords: cancer stratified; khorana score; risk; cancer ... See more keywords
Podoplanin promotes cancer-associated thrombosis and contributes to the unfavorable overall survival in an ectopic xenograft mouse model of oral cancer
Sign Up to like & getrecommendations! Published in 2019 at "Biomedical Journal"
DOI: 10.1016/j.bj.2019.07.001
Abstract: Background Podoplanin (PDPN) is a transmembrane glycoprotein that mediates tumor cell-induced platelets aggregation in different cancer types. Emerging data indicate that PDPN is a marker for poor prognosis of human oral squamous cell carcinoma (OSCC).… read more here.
Keywords: pdpn; cancer; cancer associated; associated thrombosis ... See more keywords
Symptomatic catheter-associated thrombosis in pediatric trauma patients: Choose your access wisely.
Sign Up to like & getrecommendations! Published in 2019 at "Surgery"
DOI: 10.1016/j.surg.2019.05.018
Abstract: BACKGROUND Traumatic injury and the presence of a central venous catheter are 2 of the strongest risk factors for venous thromboembolism in children. The purpose of this study was to determine the incidence of symptomatic,… read more here.
Keywords: catheter; symptomatic catheter; access; catheter associated ... See more keywords
Tinzaparin in cancer associated thrombosis beyond 6months: TiCAT study.
Sign Up to like & getrecommendations! Published in 2017 at "Thrombosis research"
DOI: 10.1016/j.thromres.2017.07.004
Abstract: INTRODUCTION The safety and efficacy of low-molecular-weight heparin (LMWH) treatment in patients with cancer-associated thrombosis (CAT) beyond 6months are unknown. Our aim was to determine the safety of long-term tinzaparin use in patients with CAT.… read more here.
Keywords: tinzaparin; beyond 6months; clinically relevant; cancer associated ... See more keywords
Is COVID-19 associated thrombosis caused by overactivation of the complement cascade? A literature review
Sign Up to like & getrecommendations! Published in 2020 at "Thrombosis Research"
DOI: 10.1016/j.thromres.2020.06.027
Abstract: Abstract Severe acute respiratory syndrome coronavirus 2 is responsible for the current COVID-19 pandemic resulting in an escalating number of cases and fatalities worldwide. Preliminary evidence from these patients, as well as past coronavirus epidemics,… read more here.
Keywords: caused overactivation; covid; complement; associated thrombosis ... See more keywords
High mobility group box 1 was associated with thrombosis in patients with atrial fibrillation
Sign Up to like & getrecommendations! Published in 2018 at "Medicine"
DOI: 10.1097/md.0000000000010132
Abstract: Introduction: High mobility group box 1 (HMGB1) is a member of the HMGB family that is involved in inflammatory disease-related thrombosis. We hypothesize that HMGB1 and its downstream factors are associated with thrombosis in atrial… read more here.
Keywords: atrial fibrillation; thrombus group; group; thrombosis ... See more keywords
Unanswered questions in cancer‐associated thrombosis
Sign Up to like & getrecommendations! Published in 2022 at "British Journal of Haematology"
DOI: 10.1111/bjh.18276
Abstract: Cancer‐associated venous thromboembolism (VTE) is a leading cause of morbidity and mortality in patients with cancer. Treatment of cancer‐associated VTE comes with a heightened risk of anticoagulant‐related bleeding that differs by choice of anticoagulant as… read more here.
Keywords: questions cancer; associated thrombosis; associated vte; cancer associated ... See more keywords
The efficacy and safety of DOACs versus LMWH for cancer-associated thrombosis: A systematic review & meta-analysis.
Sign Up to like & getrecommendations! Published in 2020 at "European journal of haematology"
DOI: 10.1111/ejh.13453
Abstract: Venous thromboembolism (VTE) remains the second most common cause of death in cancer patients.1 Direct oral anticoagulants (DOACs) have revolutionized treatment of VTE, though cancer patients were underrepresented in early trials.2-4 Low-molecular weight heparins (LMWH)… read more here.
Keywords: review meta; systematic review; cancer; cancer associated ... See more keywords
Cancer-Associated Thrombosis: Not All Low-Molecular-Weight Heparins Are the Same, Focus on Tinzaparin, A Narrative Review
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Clinical Practice"
DOI: 10.1155/2022/2582923
Abstract: Cancer-associated thrombosis (CAT) is the second main cause of cancer death with high related mortality and morbidity, leading to anticancer agent delays and interruptions. The recommended therapy, low-molecular-weight heparin (LMWH), however, is burdensome for patients… read more here.
Keywords: associated thrombosis; molecular weight; cancer associated; cancer ... See more keywords
ClotAssist: A program to treat cancer-associated thrombosis in an outpatient pharmacy setting
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Oncology Pharmacy Practice"
DOI: 10.1177/1078155218760704
Abstract: Stable cancer patients diagnosed with a pulmonary embolus or deep vein thrombosis are commonly referred to the emergency department for management. This practice strains an already overburdened emergency department and is associated with long wait… read more here.
Keywords: pilot study; pharmacy; cancer; cancer associated ... See more keywords
Cancer associated thrombosis in patients taking direct oral anticoagulants (DOACs): Retrospective review of a single institutional series.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.e14080
Abstract: e14080Background: Venous thromboembolism (VTE) is a common and often serious complication for patients with malignancy. Even though low molecular weight heparin (LMWH) is recommended as first line ... read more here.
Keywords: taking direct; patients taking; direct oral; thrombosis patients ... See more keywords